Ralph T. Iannelli

Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX.

Essex Capital Corp. provides financial services. The firm arranges debt or equity financing in market segments that include financing of individual transactions, vendor programs, structured finance, venture capital leasing and sale and leaseback. It also provides equipment-leasing options to companies in all stages of the company lifecycle including early and emerging companies with existing venture capital as well as publicly traded companies. The firm acquires existing leases from banks and other leasing companies, offering financing for those lessees who want to acquire equipment on an operating or capital lease basis. The company was founded in 1993 by Ralph T. Iannelli, Jr. and is headquartered in Santa Barbara, CA.

Emida Technologies, Inc. provides prepayment and transfer services. Its products and services include bill pay, debit platform, direct top-up, entertainment, international top-up, prepaid long distance, prepaid wireless, world-gift, and QR code top-up. The company was founded by David D. Brillembourg in 2001 and is headquartered in Foothill Ranch, CA.